CASI Pharmaceuticals Inc (NASDAQ:CASI)

1.48
Delayed Data
As of May 01
 +0.07 / +4.96%
Today’s Change
1.07
Today|||52-Week Range
2.09
+11.28%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-4.6M-14.5M-5.7M-26.2M
 
 
 
 
 
Depreciation38.1K20.5K17.4K48.2K
 
 
 
 
 
Total Other Cash Flow600.2K11.0M2.0M21.9M
 
 
 
 
 
Funds From Operations-3.9M-3.5M-3.7M-4.3M
 
 
 
 
 
Funds From/For Other Operating Expenses352.1K-1.3M-400.9K-273.7K
 
 
 
 
 
Net Cash Flow - Operating Activities-4.3M-2.2M-3.3M-4.0M
 
 
 
 
 
 
InvestingDecrease In Investments26.8K0.000.000.00
 
 
Capital Expenditures-6.0K-48.4K-43.0K-231.8K
 
 
 
 
 
Other Investing - Uses0.000.000.00-234.5K
 
 
Other Investing - Sources56.5K0.000.000.00
 
 
Net Cash Flow Investing77.3K-48.4K-43.0K-466.3K
 
 
 
 
 
 
FinancingShort Term Borrowings-757.5K0.000.000.00
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale1.1M9.9M10.4M0.00
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.00684.0K0.000.00
 
 
Net Cash Flow - Financing389.6K9.2M10.4M0.00
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash-3.8M7.0M7.1M-4.5M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account